Literature DB >> 30706514

The mental health burden in acne vulgaris and rosacea: an analysis of the US National Inpatient Sample.

V Singam1, S Rastogi1, K R Patel1, H H Lee1, J I Silverberg2.   

Abstract

BACKGROUND: Little is known about the mental health (MH) hospitalization among patients with acne and rosacea. AIMS: To determine the MH disorders and cost burden associated with acne and rosacea.
METHODS: Data were examined from the 2002-2012 US National Inpatient Sample, comprising a sample of ~20% of all US paediatric and adult hospitalizations (n = 87 053 155 admissions).
RESULTS: A diagnosis of ≥ 1 MH disorder was much more common among all inpatients with vs. those without a diagnosis of acne (43.7% vs. 20.0%, respectively) and rosacea (35.1% vs. 20.0%, respectively). In multivariable logistic regression models controlling for sex, age, race/ethnicity and insurance status, acne (adjusted OR = 13.02; 95% CI 11.75-14.42) and rosacea (adjusted OR = 1.70; 95% CI 1.56-1.95) were associated with significantly higher odds of a primary admission for an MH disorder (13 and 8, respectively, of 15 MH disorders examined). Both acne and rosacea were associated with higher risk of mood, anxiety, impulse control and personality disorders, and with > $2 million of excess mean annual costs of hospitalization for MH disorders in the USA.
CONCLUSION: In this study, inpatients with acne or rosacea had increased odds of comorbid MH disorders. In particular, there was an increased number of hospital admissions secondary to a primary MH disorder with coexistent acne/rosacea. MH comorbidities were associated with considerable excess costs among inpatients with acne or rosacea.
© 2019 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2019        PMID: 30706514     DOI: 10.1111/ced.13919

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

Review 1.  Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager.

Authors:  Laura Ragmanauskaite; Benjamin Kahn; BaoChau Ly; Howa Yeung
Journal:  Dermatol Clin       Date:  2019-11-26       Impact factor: 3.478

2.  Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.

Authors:  Yoshiki Miyachi; Kenshi Yamasaki; Tomomitsu Fujita; Chie Fujii
Journal:  J Dermatol       Date:  2021-12-01       Impact factor: 3.468

Review 3.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

4.  Genome-wide association meta-analysis identifies 29 new acne susceptibility loci.

Authors:  Brittany L Mitchell; Jake R Saklatvala; Nick Dand; Fiona A Hagenbeek; Xin Li; Josine L Min; Laurent Thomas; Meike Bartels; Jouke Jan Hottenga; Michelle K Lupton; Dorret I Boomsma; Xianjun Dong; Kristian Hveem; Mari Løset; Nicholas G Martin; Jonathan N Barker; Jiali Han; Catherine H Smith; Miguel E Rentería; Michael A Simpson
Journal:  Nat Commun       Date:  2022-02-07       Impact factor: 14.919

5.  Depression and Anxiety in Rosacea Patients: A Systematic Review and Meta-Analysis.

Authors:  Ru Dai; BingJiang Lin; Xuetong Zhang; Yuchen Lou; Suling Xu
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-18

6.  Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities.

Authors:  Giuseppe Lanza; Filomena Irene Ilaria Cosentino; Raffaele Ferri; Bartolo Lanuzza; Maddalena Siragusa; Mariangela Tripodi; Carmelo Schepis
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

Review 7.  Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris.

Authors:  Caitlin M Brumfiel; Meera H Patel; Katheryn A Bell; Michael A Cardis
Journal:  Ther Clin Risk Manag       Date:  2021-07-26       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.